Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) IndexJoseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Transplantation and Cellular Therapy|April 23, 2023
Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101Najla El Jurdi, Michael J Martens, Claudio G Brunstein, et al.
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
The Lancet. Child & Adolescent Health|September 1, 2024
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort studyJustine Kahn, Ruta Brazauskas, Stephanie Bo-Subait, et al.
Blood Advances|March 14, 2020
Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemiaCatherine J Lee, Soyoung Kim, Heather R Tecca, et al.
Leukemia & Lymphoma|August 31, 2017
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationAllison Winter, Lisa Rybicki, Shetal N Shah, et al.
Blood Cancer Journal|January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Blood Advances|September 14, 2021
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD ConsortiumZachariah DeFilipp, Amin M Alousi, Joseph A Pidala, et al.
Pageof 18